Cargando…
Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization
Renin-angiotensin-aldosterone system inhibitor (RAASi) therapy has been shown to improve outcomes among patients with congestive heart failure, diabetes, or renal dysfunction. These patients are also at risk for the development of hyperkalemia (HK), often leading to down-titration and/or discontinua...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946143/ https://www.ncbi.nlm.nih.gov/pubmed/31910208 http://dx.doi.org/10.1371/journal.pone.0226844 |